Data as of November 13, 2026
Edarbi 40 mg Tablet
AZILSARTAN KAMEDOXOMIL
Brand: Edarbi
Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.
Price per fill
NADAC (acquisition)
$350.92/ fill$8.28 / EA
VA Big4
$162.07/ fill$3.82 / EA
Medicaid FFS
$382.56/ fill
Medicaid MCO
$247.50/ fill
Sources: cms/nadac:price-ladder · va/fss-drug-prices:normalized · cms/sdud
What's in the reimbursement
Ingredient cost (42.4 units/fill)$350.92
Dispensing fee & other (state-fixed, not margin)$31.64
Total reimbursed per fill$382.56
The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.
Medicaid volume backing this card: 3 fee-for-service states, 6 managed-care states.
Full methodology and source columns: /tools/drug-prices/methodology